Adj. Assoc. Prof. Gregory Siller, Specialist Dermatologist

Adjunct Associate Professor Gregory Siller is the Practice Principal of Central Brisbane Dermatology.

Dr Greg Siller, Specialist Dermatologist

  • Graduate, The University of Queensland Medical School (1985).
  • Fellow, Australasian College of Dermatologists (1994).
  • Senior Visiting Medical Officer, Department of Dermatology, Princess Alexandra Hospital. (1999)
  • Adjunct Associate Professor, The University of Queensland, Faculty of Medicine, PAH – Southside Clinical Unit. (2014)
  • Member, Great Court Society, The University of QLD
  • Developer of the Teledermatologist Expert Skin Advisory website (2014)
  • Presidential Citation from The Australasian College of Dermatologists – In recognition of contribution to the Australasian College of Dermatologists. (2016)
  • Sabbatical studies at the West Suffolk Hospital UK, part of the Cambridge University Hospitals Teaching Trust (2004).
  • Sabbatical studies Medical University of Graz in Austria (part 2008/9).
  • Active participant in Continuing Professional Development Programs of the Australasian College of Dermatologists including publications, presentations to GP’s and Specialists, reviewing, teaching, examining, clinical research, representation to industry and advisory panels.
  • Certificate of Meritorious Service from The Australasian College of Dermatologists 2022 for service and dedication to The College.

Adj. Assoc. Prof. Siller’s particular interest is in the assessment and treatment of skin cancer and particularly the non-surgical management of skin cancers where he has extensive and widely recognised expertise and has been involved in research and publications for many years.  With his long term experience in skin cancer research, Central Brisbane Dermatology can reassure patients that we offer world class standards in skin cancer treatment frequently before they are conventionally available. His current research is in the fields of nanopatch vaccine delivery technology as well as genetically modified Adeno-virus therapies for skin cancer.

He also has a specialty interest in the assessment of allergic contact dermatitis and is one of the few dermatologists who perform specialised allergy patch testing in house.

Since his high school years when he conducted voice transmission through fibre optic cables and making holograms using Helium-Neon lasers, Adj. Assoc. Prof. Siller has a keen interest in lasers and has extensive experience with medical therapeutic lasers – understanding the benefits, and the limitations of them. He does not use lasers purely for cosmetic reasons.

Related interests

  • Past-Chair of the Queensland Faculty of the Australasian College of Dermatologists having also previously served as Secretary.
  • Previous or Current Member, Australian Advisory Panels, or Advisor to industry including Peplin, Galderma, Shire Pharmaceuticals, Stiefel, CSL Biotherapeutics, BioLineRx,  Schering-Plough, Wyeth/Pfizer, Abbott/Abbvie Australasia, Implicit Bioscience, Roche, Janssen Cilag, Novartis, Ascend and Celgene.
  • Numerous highly cited publications in peer reviewed journals. His paper on Ingenol Mebutate is one of the highest cited paper in the Australasian Journal of Dermatology.
  • Guest reviewer for the Australasian Journal of Dermatology and The Medical Journal of Australia.
  • 35 year Member of the Australian Medical Association.
  • Previous President of The University of Qld Medical (students) Society